447 related articles for article (PubMed ID: 22510761)
21. Urothelial neoplasms of the urinary bladder occurring in young adult and pediatric patients: a comprehensive review of literature with implications for patient management.
Paner GP; Zehnder P; Amin AM; Husain AN; Desai MM
Adv Anat Pathol; 2011 Jan; 18(1):79-89. PubMed ID: 21169741
[TBL] [Abstract][Full Text] [Related]
22. Urothelial neoplasms in patients 20 years or younger: a clinicopathological analysis using the world health organization 2004 bladder consensus classification.
Fine SW; Humphrey PA; Dehner LP; Amin MB; Epstein JI
J Urol; 2005 Nov; 174(5):1976-80. PubMed ID: 16217372
[TBL] [Abstract][Full Text] [Related]
23. Invasive micropapillary urothelial carcinoma of the bladder.
Lopez-Beltran A; Montironi R; Blanca A; Cheng L
Hum Pathol; 2010 Aug; 41(8):1159-64. PubMed ID: 20381120
[TBL] [Abstract][Full Text] [Related]
24. Urothelial carcinoma "nested variant" of renal pelvis and ureter.
Pusztaszeri M; Hauser J; Iselin C; Egger JF; Pelte MF
Urology; 2007 Apr; 69(4):778.e15-7. PubMed ID: 17445674
[TBL] [Abstract][Full Text] [Related]
25. Measuring the dimension of invasive component in pT1 urothelial carcinoma in transurethral resection specimens can predict time to recurrence.
Hu Z; Mudaliar K; Quek ML; Paner GP; Barkan GA
Ann Diagn Pathol; 2014 Apr; 18(2):49-52. PubMed ID: 24370460
[TBL] [Abstract][Full Text] [Related]
26. Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis.
Lopez-Beltran A; Amin MB; Oliveira PS; Montironi R; Algaba F; McKenney JK; de Torres I; Mazerolles C; Wang M; Cheng L
Am J Surg Pathol; 2010 Mar; 34(3):371-6. PubMed ID: 20139762
[TBL] [Abstract][Full Text] [Related]
27. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
Tamas EF; Epstein JI
Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
[TBL] [Abstract][Full Text] [Related]
28. Renal cell carcinoma invading the urinary collecting system: implications for staging.
Uzzo RG; Cherullo E; Myles J; Novick AC
J Urol; 2002 Jun; 167(6):2392-6. PubMed ID: 11992044
[TBL] [Abstract][Full Text] [Related]
29. Lipoid-cell variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of five cases.
Leroy X; Gonzalez S; Zini L; Aubert S
Am J Surg Pathol; 2007 May; 31(5):770-3. PubMed ID: 17460462
[TBL] [Abstract][Full Text] [Related]
30. Squamous cell carcinoma of the renal pelvis and ureter: incidence, symptoms, treatment and outcome.
Holmäng S; Lele SM; Johansson SL
J Urol; 2007 Jul; 178(1):51-6. PubMed ID: 17574059
[TBL] [Abstract][Full Text] [Related]
31. Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy.
Ouzzane A; Colin P; Xylinas E; Pignot G; Ariane MM; Saint F; Hoarau N; Adam E; Azemar MD; Bensadoun H; Cormier L; Cussenot O; Houlgatte A; Karsenty G; Bruyère F; Maurin C; Nouhaud FX; Phe V; Polguer T; Roumiguié M; Ruffion A; Rouprêt M;
Eur Urol; 2011 Dec; 60(6):1258-65. PubMed ID: 21665356
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.
Terakawa T; Miyake H; Muramaki M; Takenaka A; Hara I; Fujisawa M
Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379
[TBL] [Abstract][Full Text] [Related]
33. Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall.
Gordetsky J; Epstein JI
Am J Surg Pathol; 2014 Jul; 38(7):941-5. PubMed ID: 24503758
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
[TBL] [Abstract][Full Text] [Related]
35. Utility of ProEx C in the histologic evaluation of the neoplastic and nonneoplastic urothelial lesions.
Moatamed NA; Vergara-Lluri ME; Lu D; Apple SK; Kerkoutian S; Rao JY
Hum Pathol; 2013 Nov; 44(11):2509-17. PubMed ID: 24029711
[TBL] [Abstract][Full Text] [Related]
36. Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma.
Krambeck AE; Thompson RH; Lohse CM; Patterson DE; Segura JW; Zincke H; Elliott DS; Blute ML
J Urol; 2007 May; 177(5):1721-6. PubMed ID: 17437796
[TBL] [Abstract][Full Text] [Related]
37. Urothelial carcinoma involving the ureteral orifice: a clinicopathologic analysis of 93 cases.
Annan AC; Stevens KA; Osunkoya AO
Hum Pathol; 2017 Jul; 65():101-106. PubMed ID: 28465130
[TBL] [Abstract][Full Text] [Related]
38. Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location.
Zigeuner RE; Hutterer G; Chromecki T; Rehak P; Langner C
BJU Int; 2006 Dec; 98(6):1181-6. PubMed ID: 17125475
[TBL] [Abstract][Full Text] [Related]
39. Urinary bladder biopsy with denuded mucosa: denuding cystitis-cytopathologic correlates.
Parwani AV; Levi AW; Epstein JI; Ali SZ
Diagn Cytopathol; 2004 May; 30(5):297-300. PubMed ID: 15108225
[TBL] [Abstract][Full Text] [Related]
40. Urothelial carcinoma with rhabdoid features: report of 6 cases.
Parwani AV; Herawi M; Volmar K; Tsay SH; Epstein JI
Hum Pathol; 2006 Feb; 37(2):168-72. PubMed ID: 16426916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
